CD8A and glioblastoma: There was a statistical increase in specific ROIs (CD4, CD14, CD68, CD8A, B7-H3, PDL-1, CD19, FOXP3, CD44, and STAT3) protein expression in methylated versus unmethylated GBM tumor core.